Han Xu, M.d., Ph.d., Fapcr, Sponsor-investigator, Irb Chair

This is a very small, early-stage study testing whether a new biological treatment can help control HIV. The trial involves 20 HIV-positive patients without AIDS symptoms, who receive a combination treatment through skin injections. Researchers are looking to see if this approach…

This study aims to understand how a person's genetic makeup influences their response to the chemotherapy drug topotecan for small cell lung cancer. Researchers will analyze the genes of 600 patients to see if specific genetic variations predict how well the drug works or what si…

This study aims to understand how a person's genes affect their response to the drug raloxifene, which is used to reduce breast cancer risk in people with a condition called LCIS. Researchers will analyze genetic data from 600 patients to see if specific gene variations predict h…